| Serial Number | 79398080 |
| Word Mark | BCALDIAGNOSTICS |
| Filing Date | Tuesday, March 26, 2024 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Saturday, October 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Chemical preparations for testing blood for medical purposes; diagnostic preparations for clinical, medical or veterinary laboratory use; diagnostic preparations for medical purposes; diagnostic products in the nature of medical diagnostic biomarkers for medical purposes; diagnostic substances for medical use; diagnostic testing materials in the nature of diagnostic test patch for application to the skin for determining allergies for medical use; diagnostic agents for pharmaceutical use; diagnostic reagents for medical purposes; preparations for medical diagnostic use; reagents for blood grouping for medical purposes; blood testing apparatus including test erythrocytes for blood diagnostic purposes; medical adhesive tapes; medical dressings; medical or veterinary chemical products in the nature of chemical reagents for diagnostic tests for medical use; medical or veterinary chemical products in the nature of chemical reagents for use in biological preparations for medical purposes; medical or veterinary chemical products in the nature of chemical reagents for use with biotechnology for medical purposes; medical or veterinary chemical preparations in the nature of chemical reagents for the vaccines and antibodies chemical products in the nature of chemical reagents for medical or veterinary purposes; medical or veterinary chemical preparations for therapeutic, sanitary or pharmaceutical purposes, namely, for modulate or modify lipids to improve disease outcomes for conditions including, dyslipidemia, hypolipidemia, cardiovascular disease, kidney disease, diabetes, fatty liver disease, obesity, vascular disease, pancreatitis, hypothyroidism, stroke, metabolic diseases, blood cancers, breast cancer, lung cancer, pancreatic cancer, ovarian cancer and other solids cancers; medical plasters; medical preparations for the treatment of dyslipidemia, hypolipidemia, cardiovascular disease, kidney disease, diabetes, fatty liver disease, obesity, vascular disease, pancreatitis, hypothyroidism, stroke, metabolic diseases, blood cancers, breast cancer, lung cancer, pancreatic cancer, ovarian cancer and other solids cancers; |
| Pseudo Mark | BCAL DIAGNOSTICS |
| Goods and Services | Medical analysis of tissues for the medical treatment of persons; blood testing services being medical analysis services for diagnostic and treatment purposes by medical laboratories; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services relating to the diagnosis and treatment of persons; medical analysis services relating to the treatment of patients; medical diagnostic testing, monitoring and reporting services; surgical diagnostic services relating to the treatment of patients for medical purposes; health screening services in the field of dyslipidemia, hypolipidemia, cardiovascular disease, kidney disease, diabetes, fatty liver disease, obesity, vascular disease, pancreatitis, hypothyroidism, stroke, metabolic diseases, blood cancers, breast cancer, lung cancer, pancreatic cancer, ovarian cancer and other solids cancers; medical screening; medical services; medical monitoring and reporting services of patients; remote monitoring of medical data for medical diagnosis and treatment |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BCal Diagnostics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | AU |
| Event Date | Event Description |
| Thursday, June 20, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Sunday, July 14, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, July 14, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, July 22, 2024 | ASSIGNED TO EXAMINER |
| Monday, July 29, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 30, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, August 10, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, September 20, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Saturday, August 10, 2024 | REFUSAL PROCESSED BY MPU |
| Sunday, September 1, 2024 | REFUSAL PROCESSED BY IB |
| Friday, September 20, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, September 20, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, September 20, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, September 20, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, September 23, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 23, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, October 19, 2024 | FINAL REFUSAL E-MAILED |
| Saturday, October 19, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Saturday, October 19, 2024 | FINAL REFUSAL WRITTEN |
| Monday, September 23, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |